Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol (Q74593927)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10071526%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

title

Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10071526%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

1 reference

Blake K

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10071526%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Pearlman DS

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10071526%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Scott C

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10071526%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Wang Y

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10071526%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Stahl E

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10071526%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

Arledge T

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10071526%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 February 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10071526%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

11 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10071526%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

82

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10071526%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10071526%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

205-211

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10071526%20AND%20SRC:MED&resulttype=core&format=json

Standardization of exercise tests in asthmatic children

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962598-7

7 January 2021

The response to exercise in normal and asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962598-7

7 January 2021

Use of serial exercise tests to assess the efficacy and duration of action of drugs for asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962598-7

7 January 2021

Duration of Protection by Inhaled Salmeterol in Exercise-induced Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962598-7

7 January 2021

Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962598-7

7 January 2021

Efficacy and duration of salmeterol powder inhalation in protecting against exercise-induced bronchoconstriction

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962598-7

7 January 2021

Prevention of exercise induced asthma by inhaled salmeterol xinafoate

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962598-7

7 January 2021

Overnight protection by inhaled salmeterol on exercise-induced asthma in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962598-7

7 January 2021

Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962598-7

7 January 2021

Guidelines for the methodology of exercise challenge testing of asthmatics. Study Group on Exercise Challenge, Bronchoprovocation Committee, American Academy of Allergy.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962598-7

7 January 2021

Tolerance to the bronchoprotective effect of salmeterol in adolescents with exercise-induced asthma using concurrent inhaled glucocorticoid treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962598-7

7 January 2021

Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962598-7

7 January 2021

Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962598-7

7 January 2021

A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962598-7

7 January 2021

10.1016/S1081-1206(10)62598-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10071526%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference